_id
690f37dfccc777a4e85d181c
Ticker
BPMUF
Name
Basilea Pharmaceutica AG
Exchange
PINK
Address
Hegenheimermattweg 167b, Allschwil, Switzerland, 4123
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.basilea.com
Description
Basilea Pharmaceutica AG is a Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections. The company offers Cresemba (isavuconazole), an intravenous and oral antifungal for the treatment of invasive aspergillosis and mucormycosis; and Zevtera (ceftobiprole), an antibiotic for the treatment of pneumonia, Staphylococcus aureus bacteremia (SAB), and acute bacterial skin and skin structure infections (ABSSSI). The company also has a clinical-stage pipeline of anti-infective assets that include fosmanogepix, a broad-spectrum antifungal in phase 3 development for invasive mold and yeast infections; ceftibuten-ledaborbactam, a phase 3 - ready oral antibiotic for the treatment of complicated urinary tract infections (cUTI); BAL2062, a candidate for invasive aspergillosis currently advancing toward phase 2 clinical development; and BAL2420, a preclinical-stage antibiotic targeting severe Enterobacteriaceae infections. The company has a strategic collaboration with Prokaryotics, Inc for the development of antifungal for the treatment of severe invasive infections. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Allschwil, Switzerland.
Last Close
68.95
Volume
-
Current Price
68.95
Change
0
Last Updated
2026-01-20T16:54:24.472Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
846004736
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.975
Sentiment Sources
1
Current Quarter
2025-06-30
Revenue
103960000
Cost Of Revenue
62524000
Gross Profit
41436000
Operating Expenses
17404000
Operating Income
24032000
Interest Expense
1369000
Pretax Income
19345000
Net Income
15802000
Eps
1.1410854450731496
Dividends Per Share
-
Shares Outstanding
12269830
Income Tax Expense
3543000
EBITDA
25099000
Operating Margin
23.11658330126972
Total Other Income Expense Net
-4687000
Cash
128365000
Short Term Investments
-
Receivables
56035000
Inventories
22625000
Total Current Assets
217467000
Property Plant Equipment
17500000
Total Assets
248847000
Payables
9925000
Short Term Debt
2062000
Long Term Debt
81983000
Total Liabilities
145691000
Equity
103156000
Bs_currency_symbol
CHF
Depreciation
1334000
Change In Working Capital
2110000
Cash From Operations
23056000
Capital Expenditures
321000
Cash From Investing
-414000
Cash From Financing
-14470000
Net Change In Cash
132721000
Cf_currency_symbol
-
PE
10.11
PB
9.256220007561364
ROE
15.318546667183682
ROA
6.350086599396416
FCF
22735000
Fcf Percent
0.21868988072335513
Piotroski FScore
4
Health Score
69
Deep Value Investing Score
6
Defensive Investing Score
6
Dividend Investing Score
3
Economic Moat Investing Score
8.5
Garp Investing Score
4
Growth Investing Score
3.5
Momentum Investing Score
6.5
Net Net Investing Score
2.5
Quality Investing Score
8
Value Investing Score
6.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
103960000
Quarters > 0 > income Statement > cost Of Revenue
62524000
Quarters > 0 > income Statement > gross Profit
41436000
Quarters > 0 > income Statement > operating Expenses
17404000
Quarters > 0 > income Statement > operating Income
24032000
Quarters > 0 > income Statement > interest Expense
1369000
Quarters > 0 > income Statement > pretax Income
19345000
Quarters > 0 > income Statement > net Income
15802000
Quarters > 0 > income Statement > eps
1.1410854450731496
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
13848218
Quarters > 0 > income Statement > income Tax Expense
3543000
Quarters > 0 > income Statement > EBITDA
25099000
Quarters > 0 > income Statement > operating Margin
23.11658330126972
Quarters > 0 > income Statement > total Other Income Expense Net
-4687000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
128365000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
56035000
Quarters > 0 > balance Sheet > inventories
22625000
Quarters > 0 > balance Sheet > total Current Assets
217467000
Quarters > 0 > balance Sheet > property Plant Equipment
17500000
Quarters > 0 > balance Sheet > total Assets
248847000
Quarters > 0 > balance Sheet > payables
9925000
Quarters > 0 > balance Sheet > short Term Debt
2062000
Quarters > 0 > balance Sheet > long Term Debt
81983000
Quarters > 0 > balance Sheet > total Liabilities
145691000
Quarters > 0 > balance Sheet > equity
103156000
Quarters > 0 > balance Sheet > currency_symbol
CHF
Quarters > 0 > cash Flow > net Income
15802000
Quarters > 0 > cash Flow > depreciation
1334000
Quarters > 0 > cash Flow > change In Working Capital
2110000
Quarters > 0 > cash Flow > cash From Operations
23056000
Quarters > 0 > cash Flow > capital Expenditures
321000
Quarters > 0 > cash Flow > cash From Investing
-414000
Quarters > 0 > cash Flow > cash From Financing
-14470000
Quarters > 0 > cash Flow > net Change In Cash
132721000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
1.1410854450731496
Quarters > 0 > ratios > PB
9.256220007561364
Quarters > 0 > ratios > ROE
15.318546667183682
Quarters > 0 > ratios > ROA
6.350086599396416
Quarters > 0 > ratios > FCF
22735000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.21868988072335513
Quarters > 0 > health Score
69
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
132250000
Quarters > 1 > income Statement > cost Of Revenue
-13035000
Quarters > 1 > income Statement > gross Profit
145285000
Quarters > 1 > income Statement > operating Expenses
93364000
Quarters > 1 > income Statement > operating Income
51921000
Quarters > 1 > income Statement > interest Expense
3284000
Quarters > 1 > income Statement > pretax Income
52935000
Quarters > 1 > income Statement > net Income
56856000
Quarters > 1 > income Statement > eps
4.103633046169481
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
13855040
Quarters > 1 > income Statement > income Tax Expense
-3921000
Quarters > 1 > income Statement > EBITDA
56181500
Quarters > 1 > income Statement > operating Margin
39.25973534971644
Quarters > 1 > income Statement > total Other Income Expense Net
1014000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
120700000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
56576000
Quarters > 1 > balance Sheet > inventories
31609000
Quarters > 1 > balance Sheet > total Current Assets
220911000
Quarters > 1 > balance Sheet > property Plant Equipment
19000000
Quarters > 1 > balance Sheet > total Assets
257764000
Quarters > 1 > balance Sheet > payables
11487000
Quarters > 1 > balance Sheet > short Term Debt
2062000
Quarters > 1 > balance Sheet > long Term Debt
95912000
Quarters > 1 > balance Sheet > total Liabilities
176765000
Quarters > 1 > balance Sheet > equity
80999000
Quarters > 1 > balance Sheet > currency_symbol
CHF
Quarters > 1 > cash Flow > net Income
56856000
Quarters > 1 > cash Flow > depreciation
535000
Quarters > 1 > cash Flow > change In Working Capital
8221000
Quarters > 1 > cash Flow > cash From Operations
56443000
Quarters > 1 > cash Flow > capital Expenditures
1325000
Quarters > 1 > cash Flow > cash From Investing
-1272000
Quarters > 1 > cash Flow > cash From Financing
-22000
Quarters > 1 > cash Flow > net Change In Cash
55090000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
4.103633046169481
Quarters > 1 > ratios > PB
11.794034593019667
Quarters > 1 > ratios > ROE
70.19345917850838
Quarters > 1 > ratios > ROA
22.05738582579414
Quarters > 1 > ratios > FCF
55118000
Quarters > 1 > ratios > Piotroski FScore
3
Quarters > 1 > ratios > fcf Percent
0.4167712665406427
Quarters > 1 > health Score
71
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
76293000
Quarters > 2 > income Statement > cost Of Revenue
51716000
Quarters > 2 > income Statement > gross Profit
24577000
Quarters > 2 > income Statement > operating Expenses
15321000
Quarters > 2 > income Statement > operating Income
9256000
Quarters > 2 > income Statement > interest Expense
7628000
Quarters > 2 > income Statement > pretax Income
7325000
Quarters > 2 > income Statement > net Income
20737000
Quarters > 2 > income Statement > eps
1.5003162044640792
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
13821753
Quarters > 2 > income Statement > income Tax Expense
-13412000
Quarters > 2 > income Statement > EBITDA
10154500
Quarters > 2 > income Statement > operating Margin
12.13217464249669
Quarters > 2 > income Statement > total Other Income Expense Net
-1931000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
62963000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
28080000
Quarters > 2 > balance Sheet > inventories
31375000
Quarters > 2 > balance Sheet > total Current Assets
155013000
Quarters > 2 > balance Sheet > property Plant Equipment
19412000
Quarters > 2 > balance Sheet > total Assets
188663000
Quarters > 2 > balance Sheet > payables
11471000
Quarters > 2 > balance Sheet > short Term Debt
2062000
Quarters > 2 > balance Sheet > long Term Debt
95683000
Quarters > 2 > balance Sheet > total Liabilities
171877000
Quarters > 2 > balance Sheet > equity
16787000
Quarters > 2 > balance Sheet > currency_symbol
CHF
Quarters > 2 > cash Flow > net Income
20737000
Quarters > 2 > cash Flow > depreciation
1197000
Quarters > 2 > cash Flow > change In Working Capital
1152000
Quarters > 2 > cash Flow > cash From Operations
17920000
Quarters > 2 > cash Flow > capital Expenditures
467000
Quarters > 2 > cash Flow > cash From Investing
261000
Quarters > 2 > cash Flow > cash From Financing
-13142000
Quarters > 2 > cash Flow > net Change In Cash
56981000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
1.5003162044640792
Quarters > 2 > ratios > PB
56.77070765175434
Quarters > 2 > ratios > ROE
123.53011258712098
Quarters > 2 > ratios > ROA
10.991556373003714
Quarters > 2 > ratios > FCF
17453000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.22876279606254835
Quarters > 2 > health Score
67
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
38146500
Quarters > 3 > income Statement > cost Of Revenue
25858000
Quarters > 3 > income Statement > gross Profit
12288500
Quarters > 3 > income Statement > operating Expenses
7660500
Quarters > 3 > income Statement > operating Income
4628000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
3662500
Quarters > 3 > income Statement > net Income
10368500
Quarters > 3 > income Statement > eps
0.7501581022320396
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
13821753
Quarters > 3 > income Statement > income Tax Expense
6706000
Quarters > 3 > income Statement > EBITDA
5077250
Quarters > 3 > income Statement > operating Margin
12.13217464249669
Quarters > 3 > income Statement > total Other Income Expense Net
-965500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
10368500
Quarters > 3 > cash Flow > depreciation
598500
Quarters > 3 > cash Flow > change In Working Capital
576000
Quarters > 3 > cash Flow > cash From Operations
8960000
Quarters > 3 > cash Flow > capital Expenditures
233500
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-6571000
Quarters > 3 > cash Flow > net Change In Cash
2574000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.7501581022320396
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
8726500
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.22876279606254835
Quarters > 3 > health Score
65
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
208543000
Annuals > 0 > income Statement > cost Of Revenue
38681000
Annuals > 0 > income Statement > gross Profit
169862000
Annuals > 0 > income Statement > operating Expenses
108685000
Annuals > 0 > income Statement > operating Income
61177000
Annuals > 0 > income Statement > interest Expense
4344000
Annuals > 0 > income Statement > pretax Income
60260000
Annuals > 0 > income Statement > net Income
77593000
Annuals > 0 > income Statement > eps
5.600344712104765
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
13855040
Annuals > 0 > income Statement > income Tax Expense
-17333000
Annuals > 0 > income Statement > EBITDA
66336000
Annuals > 0 > income Statement > operating Margin
29.33543681638799
Annuals > 0 > income Statement > total Other Income Expense Net
-917000
Annuals > 0 > income Statement > currency_symbol
CHF
Annuals > 0 > balance Sheet > cash
120700000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
56576000
Annuals > 0 > balance Sheet > inventories
31609000
Annuals > 0 > balance Sheet > total Current Assets
220911000
Annuals > 0 > balance Sheet > property Plant Equipment
19000000
Annuals > 0 > balance Sheet > total Assets
257764000
Annuals > 0 > balance Sheet > payables
11487000
Annuals > 0 > balance Sheet > short Term Debt
2062000
Annuals > 0 > balance Sheet > long Term Debt
95912000
Annuals > 0 > balance Sheet > total Liabilities
176765000
Annuals > 0 > balance Sheet > equity
80999000
Annuals > 0 > balance Sheet > currency_symbol
CHF
Annuals > 0 > cash Flow > net Income
77593000
Annuals > 0 > cash Flow > depreciation
1732000
Annuals > 0 > cash Flow > change In Working Capital
9373000
Annuals > 0 > cash Flow > cash From Operations
74363000
Annuals > 0 > cash Flow > capital Expenditures
1792000
Annuals > 0 > cash Flow > cash From Investing
-1011000
Annuals > 0 > cash Flow > cash From Financing
-13164000
Annuals > 0 > cash Flow > net Change In Cash
60238000
Annuals > 0 > cash Flow > currency_symbol
CHF
Annuals > 0 > ratios > PE
5.600344712104765
Annuals > 0 > ratios > PB
11.794034593019667
Annuals > 0 > ratios > ROE
95.79500981493598
Annuals > 0 > ratios > ROA
30.102341676882734
Annuals > 0 > ratios > FCF
72571000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.34799058227799545
Annuals > 0 > health Score
71
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
157634000
Annuals > 1 > income Statement > cost Of Revenue
26794000
Annuals > 1 > income Statement > gross Profit
130840000
Annuals > 1 > income Statement > operating Expenses
111635000
Annuals > 1 > income Statement > operating Income
19205000
Annuals > 1 > income Statement > interest Expense
11202000
Annuals > 1 > income Statement > pretax Income
10461000
Annuals > 1 > income Statement > net Income
10451000
Annuals > 1 > income Statement > eps
0.8606550053170213
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
12143077
Annuals > 1 > income Statement > income Tax Expense
10000
Annuals > 1 > income Statement > EBITDA
23240000
Annuals > 1 > income Statement > operating Margin
12.183285331844653
Annuals > 1 > income Statement > total Other Income Expense Net
-8744000
Annuals > 1 > income Statement > currency_symbol
CHF
Annuals > 1 > balance Sheet > cash
59900000
Annuals > 1 > balance Sheet > short Term Investments
51833000
Annuals > 1 > balance Sheet > receivables
27891000
Annuals > 1 > balance Sheet > inventories
26410000
Annuals > 1 > balance Sheet > total Current Assets
152145000
Annuals > 1 > balance Sheet > property Plant Equipment
20552000
Annuals > 1 > balance Sheet > total Assets
173289000
Annuals > 1 > balance Sheet > payables
5847000
Annuals > 1 > balance Sheet > short Term Debt
17515000
Annuals > 1 > balance Sheet > long Term Debt
95455000
Annuals > 1 > balance Sheet > total Liabilities
183291000
Annuals > 1 > balance Sheet > equity
-10002000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
10451000
Annuals > 1 > cash Flow > depreciation
1577000
Annuals > 1 > cash Flow > change In Working Capital
-5225000
Annuals > 1 > cash Flow > cash From Operations
14245000
Annuals > 1 > cash Flow > capital Expenditures
1034000
Annuals > 1 > cash Flow > cash From Investing
-1034000
Annuals > 1 > cash Flow > cash From Financing
-57305000
Annuals > 1 > cash Flow > net Change In Cash
-44245000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.8606550053170213
Annuals > 1 > ratios > PB
-83.70977396020795
Annuals > 1 > ratios > ROE
-104.48910217956409
Annuals > 1 > ratios > ROA
6.030965612358545
Annuals > 1 > ratios > FCF
13211000
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
0.0838080617125747
Annuals > 1 > health Score
44
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
147765000
Annuals > 2 > income Statement > cost Of Revenue
24603000
Annuals > 2 > income Statement > gross Profit
123162000
Annuals > 2 > income Statement > operating Expenses
30815000
Annuals > 2 > income Statement > operating Income
18543000
Annuals > 2 > income Statement > interest Expense
9848000
Annuals > 2 > income Statement > pretax Income
12102000
Annuals > 2 > income Statement > net Income
12147000
Annuals > 2 > income Statement > eps
1.0170364276878057
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
11943525
Annuals > 2 > income Statement > income Tax Expense
-45000
Annuals > 2 > income Statement > EBITDA
21710000
Annuals > 2 > income Statement > operating Margin
12.548979799005178
Annuals > 2 > income Statement > total Other Income Expense Net
-6441000
Annuals > 2 > income Statement > currency_symbol
CHF
Annuals > 2 > balance Sheet > cash
84700000
Annuals > 2 > balance Sheet > short Term Investments
50000000
Annuals > 2 > balance Sheet > receivables
56552000
Annuals > 2 > balance Sheet > inventories
24244000
Annuals > 2 > balance Sheet > total Current Assets
175364000
Annuals > 2 > balance Sheet > property Plant Equipment
21600000
Annuals > 2 > balance Sheet > total Assets
220848000
Annuals > 2 > balance Sheet > payables
191000
Annuals > 2 > balance Sheet > short Term Debt
39455000
Annuals > 2 > balance Sheet > long Term Debt
131360000
Annuals > 2 > balance Sheet > total Liabilities
265856000
Annuals > 2 > balance Sheet > equity
-45008000
Annuals > 2 > balance Sheet > currency_symbol
CHF
Annuals > 2 > cash Flow > net Income
12147000
Annuals > 2 > cash Flow > depreciation
1097000
Annuals > 2 > cash Flow > change In Working Capital
-11380000
Annuals > 2 > cash Flow > cash From Operations
7056000
Annuals > 2 > cash Flow > capital Expenditures
3303000
Annuals > 2 > cash Flow > cash From Investing
91649000
Annuals > 2 > cash Flow > cash From Financing
-45246000
Annuals > 2 > cash Flow > net Change In Cash
53614000
Annuals > 2 > cash Flow > currency_symbol
CHF
Annuals > 2 > ratios > PE
1.0170364276878057
Annuals > 2 > ratios > PB
-18.29688163770885
Annuals > 2 > ratios > ROE
-26.988535371489515
Annuals > 2 > ratios > ROA
5.50016300804173
Annuals > 2 > ratios > FCF
3753000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.025398436706933307
Annuals > 2 > health Score
37
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
148122000
Annuals > 3 > income Statement > cost Of Revenue
24072000
Annuals > 3 > income Statement > gross Profit
124050000
Annuals > 3 > income Statement > operating Expenses
29706000
Annuals > 3 > income Statement > operating Income
1187000
Annuals > 3 > income Statement > interest Expense
8151000
Annuals > 3 > income Statement > pretax Income
-6794000
Annuals > 3 > income Statement > net Income
-6831000
Annuals > 3 > income Statement > eps
-0.5847470140965034
Annuals > 3 > income Statement > dividends Per Share
23212000
Annuals > 3 > income Statement > shares Outstanding
11681975
Annuals > 3 > income Statement > income Tax Expense
37000
Annuals > 3 > income Statement > EBITDA
3562000
Annuals > 3 > income Statement > operating Margin
0.8013664411768676
Annuals > 3 > income Statement > total Other Income Expense Net
-7981000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
53700000
Annuals > 3 > balance Sheet > short Term Investments
95000000
Annuals > 3 > balance Sheet > receivables
24947000
Annuals > 3 > balance Sheet > inventories
22783000
Annuals > 3 > balance Sheet > total Current Assets
241066000
Annuals > 3 > balance Sheet > property Plant Equipment
2900000
Annuals > 3 > balance Sheet > total Assets
247267000
Annuals > 3 > balance Sheet > payables
10617000
Annuals > 3 > balance Sheet > short Term Debt
124401000
Annuals > 3 > balance Sheet > long Term Debt
94544000
Annuals > 3 > balance Sheet > total Liabilities
305874000
Annuals > 3 > balance Sheet > equity
-58607000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-6831000
Annuals > 3 > cash Flow > depreciation
754000
Annuals > 3 > cash Flow > change In Working Capital
-33309000
Annuals > 3 > cash Flow > cash From Operations
-32020000
Annuals > 3 > cash Flow > capital Expenditures
860000
Annuals > 3 > cash Flow > cash From Investing
3575000
Annuals > 3 > cash Flow > cash From Financing
16640000
Annuals > 3 > cash Flow > net Change In Cash
-11303000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.5847470140965034
Annuals > 3 > ratios > PB
-13.74361725135223
Annuals > 3 > ratios > ROE
11.655604279352296
Annuals > 3 > ratios > ROA
-2.762600751414463
Annuals > 3 > ratios > FCF
-32880000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.22197917932515088
Annuals > 3 > health Score
23
Valuation > metrics > PE
10.11
Valuation > metrics > PB
9.256220007561364
Valuation > final Score
50
Valuation > verdict
104.3% Overvalued
Profitability > metrics > ROE
15.318546667183682
Profitability > metrics > ROA
7.266389843056648
Profitability > metrics > Net Margin
0.15200076952674105
Profitability > final Score
75
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
1.412336655163054
Risk > metrics > Interest Coverage
17.554419284149013
Risk > final Score
70
Risk > verdict
Low
Liquidity > metrics > Current Ratio
18.141903729039793
Liquidity > metrics > Quick Ratio
16.254442312505216
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
70
Prev Profitabilities > 0
100
Prev Profitabilities > 1
100
Prev Profitabilities > 2
65
Prev Risks > 0
58
Prev Risks > 1
11
Prev Risks > 2
43
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
50
Updated At
2026-01-20T21:31:17.184Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-17
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2021-03-31
Earnings History > 1 > report Date
2021-06-30
Earnings History > 1 > date
2021-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.9943
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.9943
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2020-12-31
Earnings History > 2 > report Date
2021-03-31
Earnings History > 2 > date
2020-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.9735
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.9735
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2020-09-30
Earnings History > 3 > report Date
2020-12-31
Earnings History > 3 > date
2020-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-1.4221
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-1.4221
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2020-06-30
Earnings History > 4 > report Date
2020-09-30
Earnings History > 4 > date
2020-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.3667
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-1.3667
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-03-31
Earnings History > 5 > report Date
2020-06-30
Earnings History > 5 > date
2020-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.4802
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0.4802
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2019-12-31
Earnings History > 6 > report Date
2020-03-31
Earnings History > 6 > date
2019-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.4728
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0.4728
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2019-09-30
Earnings History > 7 > report Date
2019-12-31
Earnings History > 7 > date
2019-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.3357
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.3357
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-06-30
Earnings History > 8 > report Date
2019-09-30
Earnings History > 8 > date
2019-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.3255
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.3255
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-30
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.7376
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.7376
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-12-31
Earnings History > 10 > report Date
2019-03-31
Earnings History > 10 > date
2018-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.7231
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.7231
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-09-30
Earnings History > 11 > report Date
2018-12-31
Earnings History > 11 > date
2018-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.4145
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.4145
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2018-06-30
Earnings History > 12 > report Date
2018-09-30
Earnings History > 12 > date
2018-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.4151
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.4151
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-03-31
Earnings History > 13 > report Date
2018-06-30
Earnings History > 13 > date
2018-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-1.0473
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-1.0473
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2017-12-31
Earnings History > 14 > report Date
2018-03-31
Earnings History > 14 > date
2017-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.0869
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-1.0869
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2017-09-30
Earnings History > 15 > report Date
2017-12-31
Earnings History > 15 > date
2017-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.0543
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.0543
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2017-06-30
Earnings History > 16 > report Date
2017-09-30
Earnings History > 16 > date
2017-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.0547
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0.0547
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-03-31
Earnings History > 17 > report Date
2017-06-30
Earnings History > 17 > date
2017-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.99
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.99
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2016-12-31
Earnings History > 18 > report Date
2017-03-31
Earnings History > 18 > date
2016-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.948
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.948
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2016-09-30
Earnings History > 19 > report Date
2016-12-31
Earnings History > 19 > date
2016-09-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-1.1347
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-1.1347
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-06-30
Earnings History > 20 > report Date
2016-09-30
Earnings History > 20 > date
2016-06-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-1.1895
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-1.1895
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2016-03-31
Earnings History > 21 > report Date
2016-06-30
Earnings History > 21 > date
2016-03-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-1.4145
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-1.4145
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2015-12-31
Earnings History > 22 > report Date
2016-03-31
Earnings History > 22 > date
2015-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.4393
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-1.4393
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2015-09-30
Earnings History > 23 > report Date
2015-12-31
Earnings History > 23 > date
2015-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-1.5455
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-1.5455
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2015-06-30
Earnings History > 24 > report Date
2015-09-30
Earnings History > 24 > date
2015-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.5847
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-1.5847
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2015-03-31
Earnings History > 25 > report Date
2015-06-30
Earnings History > 25 > date
2015-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-1.6001
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-1.6001
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2014-12-31
Earnings History > 26 > report Date
2015-03-31
Earnings History > 26 > date
2014-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-1.5439
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-1.5439
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2014-09-30
Earnings History > 27 > report Date
2014-12-31
Earnings History > 27 > date
2014-09-30
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-1.1104
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
-1.1104
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2014-06-30
Earnings History > 28 > report Date
2014-09-30
Earnings History > 28 > date
2014-06-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-1.1535
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-1.1535
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2014-03-31
Earnings History > 29 > report Date
2014-06-30
Earnings History > 29 > date
2014-03-31
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-1.1082
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
-1.1082
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2013-12-31
Earnings History > 30 > report Date
2014-03-31
Earnings History > 30 > date
2013-12-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-1.1121
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
-1.1121
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2013-09-30
Earnings History > 31 > report Date
2013-12-31
Earnings History > 31 > date
2013-09-30
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.8986
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
-0.8986
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2013-06-30
Earnings History > 32 > report Date
2013-09-30
Earnings History > 32 > date
2013-06-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.8848
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-0.8848
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2013-03-31
Earnings History > 33 > report Date
2013-06-30
Earnings History > 33 > date
2013-03-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.9521
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.9521
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2012-12-31
Earnings History > 34 > report Date
2013-03-31
Earnings History > 34 > date
2012-12-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.9489
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-0.9489
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2012-09-30
Earnings History > 35 > report Date
2012-12-31
Earnings History > 35 > date
2012-09-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-1.052
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
-1.052
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2012-06-30
Earnings History > 36 > report Date
2012-09-30
Earnings History > 36 > date
2012-06-30
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-1.0235
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
-1.0235
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2012-03-31
Earnings History > 37 > report Date
2012-06-30
Earnings History > 37 > date
2012-03-31
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-1.9022
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
-1.9022
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2011-12-31
Earnings History > 38 > report Date
2012-03-31
Earnings History > 38 > date
2011-12-31
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-1.9964
Earnings History > 38 > eps Estimate
0
Earnings History > 38 > eps Difference
-1.9964
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2011-09-30
Earnings History > 39 > report Date
2011-12-31
Earnings History > 39 > date
2011-09-30
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
USD
Earnings History > 39 > eps Actual
-2.0921
Earnings History > 39 > eps Estimate
0
Earnings History > 39 > eps Difference
-2.0921
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2011-06-30
Earnings History > 40 > report Date
2011-09-30
Earnings History > 40 > date
2011-06-30
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
USD
Earnings History > 40 > eps Actual
-2.162
Earnings History > 40 > eps Estimate
0
Earnings History > 40 > eps Difference
-2.162
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2011-03-31
Earnings History > 41 > report Date
2011-06-30
Earnings History > 41 > date
2011-03-31
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
USD
Earnings History > 41 > eps Actual
-1.2494
Earnings History > 41 > eps Estimate
0
Earnings History > 41 > eps Difference
-1.2494
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2010-12-31
Earnings History > 42 > report Date
2011-03-31
Earnings History > 42 > date
2010-12-31
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
USD
Earnings History > 42 > eps Actual
-1.1478
Earnings History > 42 > eps Estimate
0
Earnings History > 42 > eps Difference
-1.1478
Earnings History > 42 > surprise Percent
-
Earnings History > 43 > period
2010-09-30
Earnings History > 43 > report Date
2010-12-31
Earnings History > 43 > date
2010-09-30
Earnings History > 43 > before After Market
-
Earnings History > 43 > currency
USD
Earnings History > 43 > eps Actual
7.359
Earnings History > 43 > eps Estimate
0
Earnings History > 43 > eps Difference
7.359
Earnings History > 43 > surprise Percent
-
Basilea Pharmaceutica AG is a Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections. The company offers Cresemba (isavuconazole), an intravenous and oral antifungal for the treatment of invasive aspergillosis and mucormycosis; and Zevtera (ceftobiprole), an antibiotic for the treatment of pneumonia, Staphylococcus aureus bacteremia (SAB), and acute bacterial skin and skin structure infections (ABSSSI). The company also has a clinical-stage pipeline of anti-infective assets that include fosmanogepix, a broad-spectrum antifungal in phase 3 development for invasive mold and yeast infections; ceftibuten-ledaborbactam, a phase 3 - ready oral antibiotic for the treatment of complicated urinary tract infections (cUTI); BAL2062, a candidate for invasive aspergillosis currently advancing toward phase 2 clinical development; and BAL2420, a preclinical-stage antibiotic targeting severe Enterobacteriaceae infections. The company has a strategic collaboration with Prokaryotics, Inc for the development of antifungal for the treatment of severe invasive infections. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Allschwil, Switzerland.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABasilea Pharmaceutica (OTCMKTS:BPMUF) Hits New 12-Month High - What's Next? MarketBeat
Read more →(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Medium
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Medium
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Basilea Pharmaceutica AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
—
Date
2021-03-31
EPS Actual
-0.9943
EPS Estimate
0
EPS Difference
-0.9943
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.